Oncology & Cancer

Cancer biomarkers re-evaluated

(Medical Xpress) -- Researchers from ETH Zurich have developed a procedure to test the clinical benefits of cancer biomarkers. The method could radically shorten the path from the lab to their application.

page 3 from 3